1. Home
  2. PCVX vs SEIC Comparison

PCVX vs SEIC Comparison

Compare PCVX & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • SEIC
  • Stock Information
  • Founded
  • PCVX 2013
  • SEIC 1968
  • Country
  • PCVX United States
  • SEIC United States
  • Employees
  • PCVX N/A
  • SEIC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • SEIC Investment Bankers/Brokers/Service
  • Sector
  • PCVX Health Care
  • SEIC Finance
  • Exchange
  • PCVX Nasdaq
  • SEIC Nasdaq
  • Market Cap
  • PCVX 4.0B
  • SEIC 10.9B
  • IPO Year
  • PCVX 2020
  • SEIC N/A
  • Fundamental
  • Price
  • PCVX $32.59
  • SEIC $86.25
  • Analyst Decision
  • PCVX Strong Buy
  • SEIC Buy
  • Analyst Count
  • PCVX 8
  • SEIC 7
  • Target Price
  • PCVX $114.17
  • SEIC $98.86
  • AVG Volume (30 Days)
  • PCVX 1.6M
  • SEIC 600.0K
  • Earning Date
  • PCVX 11-04-2025
  • SEIC 10-22-2025
  • Dividend Yield
  • PCVX N/A
  • SEIC 1.14%
  • EPS Growth
  • PCVX N/A
  • SEIC 39.15
  • EPS
  • PCVX N/A
  • SEIC 5.32
  • Revenue
  • PCVX N/A
  • SEIC $2,205,531,000.00
  • Revenue This Year
  • PCVX N/A
  • SEIC $9.97
  • Revenue Next Year
  • PCVX N/A
  • SEIC $6.97
  • P/E Ratio
  • PCVX N/A
  • SEIC $16.21
  • Revenue Growth
  • PCVX N/A
  • SEIC 10.71
  • 52 Week Low
  • PCVX $27.66
  • SEIC $64.66
  • 52 Week High
  • PCVX $121.06
  • SEIC $93.96
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 53.03
  • SEIC 41.46
  • Support Level
  • PCVX $31.47
  • SEIC $86.03
  • Resistance Level
  • PCVX $33.16
  • SEIC $88.22
  • Average True Range (ATR)
  • PCVX 1.37
  • SEIC 1.49
  • MACD
  • PCVX 0.07
  • SEIC -0.15
  • Stochastic Oscillator
  • PCVX 67.76
  • SEIC 7.89

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About SEIC SEI Investments Company

SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $87 billion in assets under management. As of December 2024, SEI (including LSV) manages, administers, or advises about $1.6 trillion in assets.

Share on Social Networks: